Search results
Lilly(Eli) & Co [LLY] SVP, Finance, & CAO makes an insider sale of 750 shares worth $0.57 million. –...
Knox Daily· 3 days agoDeutsche Bank started covering the stock on November 09, 2023. It rated LLY as “a Hold”. Price Performance Review of LLY< ...
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
InvestorPlace· 3 days agoHigh interest rates are here to stay. Federal Reserve Chairman Jerome Powell said the fight against...
1 No-Brainer Growth Stock to Buy and Hold
Motley Fool via Yahoo Finance· 5 days agoThen there is donanemab, Eli Lilly's potential therapy for Alzheimer's disease (AD) that the FDA is currently considering. An approval here could jolt...
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks· 2 days agoFree Report) announced a settlement agreement with Totality Medispa that sold compounded products in...
Earnings-Proof Tech Plays: 3 Stocks Set to Stay Hot Beyond Reporting Season
InvestorPlace via Yahoo Finance· 6 days agoDepending on where you look, there has been quite a tough crowd of investors to please this earnings...
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 2 days agoFind out why three Motley Fool contributors picked Eli Lilly (NYSE: LLY), AbbVie (NYSE: ABBV), and...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. | The Motley Fool
The Motley Fool· 6 days agoThanks to their market-leading positions and blockbuster drugs, stocks like Novo Nordisk (NVO...
IBD Live Q&A, Stock Lists For Thursday, May 16, 2024
Investor's Business Daily· 5 hours agoWelcome to IBD Live! This list of FAQs and useful links will speed your learning curve. The Ready List contains top stocks that meet our fundamental and technical screening criteria that are ...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 12 hours agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Is Eli Lilly's Latest Deal a Gamechanger? | The Motley Fool
The Motley Fool· 2 days agoDiabetes and obesity treatments from Novo Nordisk, such as Ozempic, Rybelsus, and Wegovy, are taking...
